Resultados: 2

WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia

World Health Organization.

In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. This decision was based on new evidence on the ...

Inhibidores de Agregación Plaquetaria/uso terapéutico, Preeclampsia/prevención & control, Eclampsia/prevención & control

Texto completo (enlace principal) Texto completo (enlace alternativo)

WHO recommendations: drug treatment for severe hypertension in pregnancy

World Health Organization.

Hypertensive disorders of pregnancy are an important cause of severe morbidity, long-term disability and death among both pregnant women and their babies, and account for approximately 14% of all maternal deaths worldwide. Improving care for women around the time of childbirth is a necessary step towards...

Antihipertensivos/uso terapéutico, Preeclampsia/tratamiento farmacológico, Servicios de Salud Materno-Infantil, Muerte Materna/prevención & control, Complicaciones del Embarazo

Texto completo (enlace principal) Texto completo (enlace alternativo)